Matrix metalloproteinase-9 deficiency impairs host defense against abdominal sepsis

Rosemarijn Renckens1, Joris J T H Roelofs, Sandrine Florquin

  • 1Laboratory of Experimental Internal Medicine, Academic Medical Center Rm. G2-132, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. r.renckens@amc.uva.nl

Insights

Matrix metalloproteinase-9 (MMP-9) is crucial for controlling Escherichia coli peritonitis. MMP-9 deficiency impairs leukocyte migration, leading to increased bacterial load and organ damage, highlighting MMP-9

Area of Science:

  • Immunology
  • Microbiology
  • Molecular Biology

Background:

  • Matrix metalloproteinase-9 (MMP-9) plays a role in extracellular matrix degradation and leukocyte migration.
  • The specific role of MMP-9 in the innate immune response to bacterial peritonitis remains to be fully elucidated.

Purpose of the Study:

  • To investigate the role of MMP-9 in the host defense against Escherichia coli-induced peritonitis.
  • To determine the impact of MMP-9 deficiency on bacterial clearance, immune cell recruitment, and organ damage.

Main Methods:

  • Utilized gene-deficient (MMP-9(-/-)) and wild-type mice infected intraperitoneally with Escherichia coli.
  • Quantified MMP-9 mRNA and protein levels.
  • Assessed bacterial outgrowth, dissemination, cytokine and chemokine responses, leukocyte recruitment, and distant organ damage.

Main Results:

  • MMP-9(-/-) mice exhibited reduced resistance to E. coli peritonitis, with increased bacterial outgrowth and dissemination.
  • Leukocyte recruitment to the infection site was impaired in MMP-9(-/-) mice despite elevated local chemokine levels.
  • MMP-9 deficiency led to more severe distant organ damage during infection.

Conclusions:

  • MMP-9 is essential for an effective innate immune response to E. coli peritonitis.
  • MMP-9 contributes to controlling bacterial infection by facilitating leukocyte migration and limiting tissue damage.